Foundation Calculator

Patient Body Parameters Live

Calculates Total Blood Volume (TBV), Total Plasma Volume (TPV), and Red Cell Volume (RCV). Results carry forward automatically to all other calculators.

Nadler's Formula for Total Blood Volume (TBV)

Males: TBV (L) = (0.3669 × H³) + (0.03219 × W) + 0.6041 Females: TBV (L) = (0.3561 × H³) + (0.03308 × W) + 0.1833 Simplified: TBV (mL) = 70 mL/kg × Weight [Males] / 65 mL/kg [Females]

H = Height in meters · W = Weight in kg · Nadler's formula is the standard used by Spectra Optia® and Haemonetics® MCS+

📖 Nadler et al., Surgery 1962 · Lemmens et al., Obes Surg 2006

Biological Sex

Height (cm)

Weight (kg)

Hematocrit (%) Pre-procedure value

📊 Patient Parameters

Total Blood Volume (Nadler)
—
mL

TBV (Simplified)

—

Total Plasma Volume (TPV)
—
mL

Red Cell Volume (RCV)

—

Clinical Use: TPV is used to prescribe TPE volume (typically 1.0–1.5× TPV per session). RCV is used to calculate donor RBC volume for erythrocytapheresis. These values are automatically used in other calculator modules.

Parameter	Average Adult Male	Average Adult Female	Clinical Significance
TBV	5,000–6,000 mL	4,000–5,000 mL	Basis for all apheresis volume calculations
TPV	2,700–3,200 mL	2,300–2,800 mL	Determines TPE prescription volume
RCV	2,200–2,800 mL	1,600–2,200 mL	Determines RBC exchange donor volume
Hematocrit	40–52%	36–48%	Key variable; changes during procedure

Plasma Exchange Calculator

Therapeutic Plasma Exchange (TPE) Live

Calculates plasma volume to process, replacement fluid volumes, and estimated solute reduction per session. ASFA recommends 1.0–1.5× plasma volumes per session for most indications.

TPE Volume & Solute Removal

TPE Volume (mL) = Target Plasma Volumes × TPV Residual Fraction = e^(−TPE Volume / TPV) % Removed = (1 − Residual Fraction) × 100

Assumes single-compartment model, intravascular distribution, and isovolumetric exchange. Valid for IgG, IgM, fibrinogen, and other high-MW substances.

📖 ASFA 9th Edition (2023) · Cervantes et al., AJKD 2023 · Reverberi, Blood Transfus 2007

ℹ️

Auto-fill: If you calculated Patient Body Parameters first, the TPV field below is pre-filled. Otherwise, enter TPV manually.

Total Plasma Volume (TPV) mL — from Patient Parameters or enter manually

Target Plasma Volumes

Albumin % in Replacement

Number of Sessions

📊 TPE Prescription

Volume to Process (Per Session)
—
mL per session

Estimated % Removed (Per Session)
—
% of intravascular substance

Albumin Volume (5%)

—

mL per session

FFP Volume

—

mL per session

Replacement Fluid	Standard Use	Preferred When	Avoid When
5% Albumin	First-line for most indications	Routine TPE, maintenance sessions	Active bleeding, coagulopathy, TTP (use FFP)
Fresh Frozen Plasma (FFP)	TTP (mandatory), anti-GBM, HUS	Coagulopathy, factor replacement needed	Routine use (risk of allergic reactions, TRALI)
50% Albumin / 50% FFP	Compromise approach	Mild coagulopathy, last few sessions	Active TTP (use 100% FFP)
Normal Saline	Partial replacement only	Mild hyperviscosity, volume management	Full-volume replacement (hypoproteinemia risk)

Kinetics Calculator

Solute Removal Kinetics

Models the exponential removal of intravascular substances during TPE. Useful for understanding how many sessions are needed to achieve a target reduction level.

One-Compartment Removal Model

Residual Concentration (%) = 100 × e^(−v/V) Where: v = volume exchanged (mL) · V = plasma volume (mL)

Valid for high-molecular-weight substances (IgG, IgM, fibrinogen, LDL) that are predominantly intravascular.

📖 Reverberi & Reverberi, Blood Transfus 2007 · Wiener & Wexler 1946

Patient Plasma Volume (V) mL

Target Substance

Intravascular % (if custom) % of substance in plasma

Initial Concentration / Level Any unit (mg/dL, g/L, titer, etc.)

📊 Predicted Removal by Session

Session	Volume Exchanged	Residual (%)	Estimated Level	% Removed (Cumulative)

Red Cell Procedure Calculator

RBC Exchange — Procedure Setup Live

Calculates Fraction of Cells Remaining (FCR) and the Replaced: Exchange volume for automated RBC exchange. Enter patient data, select exchange type, set fluid and run targets — FCR auto-calculates from HbS% values.

RBC Exchange Core Formulas

TBV (Males, mL) = (0.3669 × H³ + 0.03219 × W + 0.6041) × 1000 TBV (Females, mL) = (0.3561 × H³ + 0.03308 × W + 0.1833) × 1000 FCR (%) = (Target HbS% / Starting HbS%) × 100 Replaced: Exchange (mL) = −ln(FCR) × TBV × √(Patient Hct × Target Hct) / Exchange Fluid Hct Predicted Post-HbS (%) = Starting HbS% × FCR

H = Height in meters · W = Weight in kg · Hct values as decimals · FCR = Fraction of Cells Remaining

📖 Nadler et al., Surgery 1962 · ASFA 9th Edition · Terumo BCT™ RBCX Protocol

Patient Data

Biological Sex

Height (cm) 30–244

Weight (kg) 2–227

TBV (mL) auto-calculated — or enter manually

Patient Hct (%) 10–80 Pre-procedure value

Blood Warmer Volume (mL) optional, 0–100 Added to total exchange volume

Fluid Data

Exchange Type

Exchange Fluid Hct (%) 10–80 Hct of donor pRBC unit(s) used

Run Targets

Quick Presets:

Target Hct (%) 20–60

Defective Red Blood Cells (%)

Starting (pre)

Target (post)

FCR (%) 1–99 — auto from HbS% or enter directly

📊 RBC Exchange — Procedure Setup Results

FCR
—
%

Replaced: Exchange
—
mL

Patient TBV

—

Predicted Post-HbS

—

Erythrocytapheresis Calculator

RBC Exchange (RBCX) — Sickle Cell Disease Live

Calculates Fraction of Cells Remaining (FCR) and donor pRBC volume needed to achieve a target post-procedure HbS%. Supports Exchange Only and Depletion/Exchange protocols.

Core Formulas — Automated RBC Exchange

FCR from HbS%: FCR = Target HbS (%) ÷ Starting HbS (%) RCV (mL) = TBV × (Pre-Hct ÷ 100) Exchange Only — Donor Volume: V_donor = TBV × [(Target Hct − Pre-Hct × FCR) ÷ Donor Hct] Units Needed: N = V_donor ÷ Unit Volume (mL)

📖 Nadler et al., Surgery 1962 · Fasano et al., Transfusion 2015 · ASFA 9th Ed. Cat I, Grade 1C

ℹ️

FCR ≠ HbS% — Key Distinction

FCR (Fraction of Cells Remaining) is the % of the patient's original RBC volume remaining after the procedure. HbS% is the % of sickled hemoglobin. FCR = HbS% only if the patient's starting HbS is 100%. For transfused patients, always calculate FCR from HbS% using the formula above.

Procedure Type

Exchange Only Depletion / Exchange

Exchange Only: Direct replacement of patient RBCs with donor RBCs. Most common. | Depletion/Exchange: Depletes patient RBCs first, then exchanges. Requires fewer donor units. Recommended when pre-Hct ≥26%.

Screen A — Patient Data

Biological Sex

Height (cm)

Weight (kg)

Pre-procedure Hct (%)

Screen B — Procedure Targets

Enter HbS% (recommended) Enter FCR% directly

Starting HbS (%)

Target HbS (%) Acute crisis: <30% · Chronic: <50%

Target FCR (%) Enter directly if known from device

Target Post-Hct (%) Typical: 30–36%

Screen C — Donor Unit Data

Donor Unit Hct (%) Typical leukoreduced pRBC: 55–70%

Unit Volume (mL) Standard pRBC unit: 250–350 mL

Quick Presets

🔴 RBC Exchange Results

FCR (Fraction of Cells Remaining)
—
% patient RBCs remaining

Donor pRBC Volume Needed
—
mL

Donor Units Needed

—

units

Patient TBV

—

mL (Nadler)

Patient RCV

—

Predicted Post-HbS

—

HbS Reduction

—

% reduction

Spectra Optia® Entry Values

Protocol

—

FCR to Enter

—

Target Hct

—

Donor Hct

—

Cell Reduction Calculator

Leukocytapheresis — WBC Reduction

Estimates post-procedure WBC count and sessions needed to reach a target WBC level. Typically indicated for symptomatic hyperleukocytosis (WBC >100×10⁹/L).

WBC Reduction Estimate

Post-WBC = Pre-WBC × (1 − Reduction Rate) Sessions to Target = log(Target/Pre) / log(1 − Rate) WBCs Removed = Pre-WBC × Rate × TBV (L)

📖 ASFA 9th Edition · Stucki et al., J Clin Apher 2012

⚠️

Emergency Threshold: Leukapheresis is typically indicated when WBC >100×10⁹/L with symptomatic leukostasis. In AML, consider at WBC >50×10⁹/L with symptoms. This is a temporizing measure — cytoreductive chemotherapy must follow.

Pre-procedure WBC (×10⁹/L)

Target WBC (×10⁹/L)

Predominant Cell Type

Patient TBV (mL) From Patient Parameters

📊 Leukocytapheresis Estimates

Estimated Post-WBC (1 Session)
—
×10⁹/L

WBC Reduction (1 Session)

—

% reduction

Sessions to Reach Target

—

sessions (estimated)

WBCs Removed (1 Session)

—

×10⁹ cells

Cellular Therapy Calculator

HPC Stem Cell Collection (Leukapheresis)

Predicts CD34+ cell yield from peripheral blood leukapheresis. Used to plan collection sessions and determine if target dose will be achieved.

CD34+ Yield Prediction

Predicted Yield = PB CD34+ (cells/µL) × 1000 × Blood Vol Processed (L) × CE₂ (%) Target Dose: ≥2×10⁶ CD34+/kg (minimum) · ≥4×10⁶ CD34+/kg (optimal)

📖 Sheppard et al., BBMT 2016 · Jacob et al., Transfusion 2021

PB CD34+ Count (cells/µL) Day-of-collection peripheral blood

Blood Volume to Process (L) Typically 3–5× TBV

Collection Efficiency (CE₂) (%) Device-specific; typically 30–50%

Recipient Weight (kg) For dose/kg calculation

📊 HPC Collection Prediction

Predicted CD34+ Yield
—
×10⁶ cells

Dose per kg (Recipient)
—
×10⁶ CD34+/kg

Target Achievement

—

vs. 4×10⁶/kg optimal

Sessions to Optimal Dose

—

sessions estimated

PB CD34+ Count	Mobilization Status	Expected Yield	Clinical Action
<5 cells/µL	Poor mobilization	Unlikely to meet minimum dose	Consider plerixafor rescue, delay collection
5–10 cells/µL	Marginal	May require multiple sessions	Proceed with caution; consider plerixafor
10–20 cells/µL	Adequate	Likely to meet minimum (2×10⁶/kg)	Proceed with collection
>20 cells/µL	Good mobilization	Likely to meet optimal (4×10⁶/kg)	Proceed; single session may suffice

Plateletpheresis Calculator

Platelet Collection Efficiency (CE)

Calculates CE1 and CE2 for plateletpheresis and estimates the therapeutic dose. Used for donor qualification, device performance monitoring, and quality control.

Collection Efficiency Formulas

CE₁ (%) = (Collected Platelets) / (Pre-count × TBV) × 100 CE₂ (%) = (Collected Platelets) / (Pre-count × WB Volume Processed) × 100 Platelet Yield = Product Volume (mL) × Product PLT Count (×10⁹/mL) Therapeutic Dose: ≥3.0×10¹¹ platelets per unit (AABB standard)

📖 Jaime-Pérez et al., J Clin Apheresis 2017 · Castillo-Aleman et al., Transfusion & Apheresis Sci 2023

Pre-procedure PLT Count (×10⁹/L)

Donor TBV (mL) From Patient Parameters

WB Volume Processed (mL)

Product Volume (mL)

Product PLT Count (×10⁹/L)

📊 Plateletpheresis Results

Platelet Yield
—
×10¹¹ platelets

Collection Efficiency (CE₁)
—
% (vs. TBV)

Collection Efficiency (CE₂)

—

% (vs. WB processed)

Therapeutic Dose Met?

—

≥3.0×10¹¹ = AABB standard

Safety Calculator

Citrate Toxicity Risk Assessment Live

Calculates citrate infusion rate and assesses hypocalcemia risk based on blood flow rate, ACD-A ratio, and patient weight.

Citrate Infusion Rate

ACD-A Infusion Rate (mL/min) = Blood Flow Rate (mL/min) ÷ Inlet:AC Ratio Citrate Dose (mg/kg/min) = [ACD-A Rate × 20.6 mg/mL] ÷ [Patient Weight (kg)] Max Safe Rate: <1.5 mg/kg/min (standard) · <1.8 mg/kg/min (absolute max)

📖 Lee et al., Transfusion Med Rev 2012 · Weinstein et al., J Clin Apheresis 2023

⚠️

High-Risk Patients: Liver disease, hypoalbuminemia, hypomagnesemia, alkalosis, pediatric patients, and patients on calcium channel blockers are at elevated risk. Consider prophylactic calcium supplementation.

Patient Weight (kg)

Blood Flow Rate (mL/min)

Inlet:AC Ratio

Procedure Type

📊 Citrate Toxicity Assessment

ACD-A Infusion Rate

—

mL/min

Citrate Dose Rate
—
mg/kg/min

Toxicity Risk Level

—

based on dose rate

Recommended Ca²⁺ Supplement

—

prophylactic action

Citrate Dose Rate vs. Safe Threshold

0Safe (<1.5)Caution (1.5–1.8)Danger (>1.8 mg/kg/min)

Severity	Symptoms	iCa²⁺ Level	Management
Mild	Perioral tingling, paresthesias, chills	0.9–1.1 mmol/L	Slow blood flow rate, oral calcium carbonate
Moderate	Muscle cramps, nausea, anxiety, tremors	0.7–0.9 mmol/L	Reduce flow rate, IV calcium gluconate 1–2 g
Severe	Tetany, carpopedal spasm, arrhythmia, hypotension	<0.7 mmol/L	Stop procedure, IV calcium gluconate 2–4 g, ECG monitoring

Lipoprotein Apheresis Calculator

LDL Apheresis Efficacy Live

Calculates acute LDL reduction per session and time-averaged LDL using the Kroon formula. Estimates treatment frequency needed to achieve target LDL levels.

LDL Reduction & Kroon Formula

Acute LDL Reduction (%) = (Pre-LDL − Post-LDL) / Pre-LDL × 100 Kroon Time-Averaged LDL = LDL_post + K × (LDL_pre − LDL_post) K = 0.73 (biweekly) · K = 0.63 (weekly) · K = 0.83 (monthly)

📖 Kroon et al., Atherosclerosis 1994

Pre-procedure LDL-C (mg/dL)

Post-procedure LDL-C (mg/dL)

Treatment Frequency

LDL Target (mg/dL) HoFH target: <100 mg/dL (ESC/EAS)

📊 LDL Apheresis Efficacy

Acute LDL Reduction
—
% per session

Time-Averaged LDL (Kroon)
—
mg/dL

Target LDL Achieved?

—

time-averaged vs. goal

Annual Sessions Needed

—

sessions/year

Patient Type	LDL Threshold	Additional Criteria	ASFA Category
HoFH — No CVD	LDL ≥300 mg/dL	Max tolerated drug therapy	Cat I, Grade 1B
HoFH — With CVD	LDL ≥200 mg/dL	Max tolerated drug therapy	Cat I, Grade 1B
HeFH — With CVD	LDL ≥160 mg/dL	Failure of drug therapy	Cat II, Grade 1B
Elevated Lp(a) — With CVD	Lp(a) ≥60 mg/dL	Progressive CVD despite LDL control	Cat II, Grade 2C

Plasma Exchange Calculator

Replacement Fluid Calculator (TPE)

Calculates albumin and FFP volumes required for a TPE procedure, estimates coagulation factor depletion with albumin-only replacement, and determines FFP unit requirements.

Replacement Fluid Formulas

Total Replacement Volume = TPV × Exchange Factor (1.0–1.5) Albumin Volume (mL) = Total Vol × Albumin Fraction FFP Volume (mL) = Total Vol × FFP Fraction FFP Units = FFP Volume ÷ 250 mL/unit Coag Factor Residual (albumin-only) = e^(−exchange vol / TPV) × 100

📖 Cervantes et al., AJKD 2023 · Zrimsek et al., J Clin Med 2024 · ASFA 9th Edition

Total Plasma Volume (mL) From Patient Body Parameters or manual entry

Exchange Factor (volumes)

Albumin Fraction (%) Remainder = FFP. Min 70% albumin recommended (AJKD 2023)

Albumin Concentration (%)

Clinical Indication

💧 Replacement Fluid Prescription

Total Replacement Volume
—
mL

Albumin Volume
—
mL

FFP Volume

—

FFP Units Needed

—

units (÷ 250 mL/unit)

Coag Factor Residual

—

% remaining after exchange

FFP Threshold Warning

—

clinical alert

Indication	Preferred Fluid	Rationale	ASFA Guidance
TTP (ADAMTS13 deficiency)	100% FFP or cryopoor plasma	Replenishes ADAMTS13	Cat I, Grade 1A
HUS (Shiga toxin)	FFP or albumin	Less clear benefit; albumin acceptable if no coagulopathy	Cat III, Grade 2C
ANCA-AAV / Anti-GBM	5% Albumin	No coagulation factor replacement needed	Cat I–II
Myasthenia Gravis / CIDP	5% Albumin	Standard; FFP only if coagulopathy present	Cat I, Grade 1B
Coagulopathy / Pre-surgical	50–100% FFP	Maintain coagulation factors ≥40% activity	Institutional protocol

Selective Apheresis Calculator

Immunoadsorption (IA) — IgG Removal

Calculates IgG removal per session and cumulative removal across multiple sessions using Protein A or other immunoadsorption columns.

Immunoadsorption IgG Removal

IgG Removed per Session (g) = [IgG] (g/L) × TPV (L) × Removal Rate Residual IgG after N sessions = IgG₀ × (1 − Removal Rate)^N Cumulative Removal % = (1 − (1 − r)^N) × 100

📖 Süfke et al., Ther Apher Dial 2017 · Giszas et al., Ther Apher Dial 2023

Patient Plasma Volume (mL) From Patient Parameters or manual entry

Baseline IgG (g/L)

IA Column Type

Number of Sessions

Target IgG (g/L) — optional

🔬 Immunoadsorption Results

IgG Removed (Session 1)
—
grams

Post-Session 1 IgG
—
g/L

Post-Final Session IgG

—

g/L

Cumulative Removal

—

% of baseline IgG

Total IgG Removed

—

grams total

Target IgG Achieved?

—

vs. goal

Indication	Target Molecule	Column Type	ASFA Category
Myasthenia Gravis (severe)	Anti-AChR / Anti-MuSK IgG	Protein A or tryptophan	Cat I, Grade 1C
ANCA-AAV (refractory)	ANCA (IgG)	Protein A	Cat II, Grade 2C
Dilated Cardiomyopathy	Anti-β1-AR IgG	Protein A	Cat II, Grade 1B
Pemphigus Vulgaris	Anti-Dsg1/3 IgG	Protein A or IA	Cat II, Grade 1C
Hemophilia A (inhibitors)	Anti-FVIII IgG	Protein A	Cat II, Grade 2C

Selective Apheresis Calculator

Double Filtration Plasmapheresis (DFPP)

Calculates sieving coefficient, removal ratio, and discard volume for DFPP. Selectively removes large-MW proteins (IgG, IgM, fibrinogen) while retaining albumin.

DFPP Sieving & Removal Formulas

Sieving Coefficient (SC): SC = C_filtrate / C_feed plasma Removal Ratio (RR): RR = 1 − (C_post / C_pre) Discard Volume: V_discard = V_plasma filtered × (1 − SC_albumin) Albumin Loss: Loss = Plasma filtered × [Albumin] × (1 − SC_albumin)

📖 Evaflux 4A default SCs: IgG 0.40 · IgM 0.05 · Fibrinogen 0.20 · Albumin 0.85

Plasma Volume Filtered (mL) Typically 1.0–1.5× TPV per session

Pre-procedure IgG (g/L)

Pre-procedure Albumin (g/L)

Plasma Fractionator

🔁 DFPP Sieving Results

IgG Removal Ratio
—
% removed per session

IgM Removal Ratio

—

% removed per session

Albumin Retained

—

% retained

Fibrinogen Removal

—

% removed

Estimated Discard Volume

—

mL (replace with 5% albumin)

Albumin Loss

—

grams

Safety Calculator

Extracorporeal Volume (ECV) Safety Check Live

Determines whether circuit priming is required based on the extracorporeal volume as a percentage of the patient's total blood volume. Critical for pediatric and small-volume patients.

ECV Safety Threshold

ECV% = (Circuit ECV mL / Patient TBV mL) × 100 Safe: ECV ≤10% TBV — no prime needed Caution: ECV 10–15% TBV — consider priming Mandatory Prime: ECV >15% TBV — prime required

In pediatric patients, pRBC prime is mandatory when ECV >15% TBV. In adults, 5% albumin or NS is acceptable.

📖 Schwartz et al., J Clin Apheresis 2016 · ASFA Pediatric Apheresis Guidelines

Patient Type

Adult Pediatric

TBV Estimation Method

Biological Sex

Height (cm) — optional For Nadler formula; leave blank for simplified

Patient Weight (kg)

Circuit / Device

Custom Circuit ECV (mL)

🛡️ ECV Safety Assessment

Patient TBV

—

ECV as % of TBV

—

% (threshold: 10–15%)

Circuit ECV

—

Prime Decision

—

clinical recommendation

Photopheresis Calculator

Extracorporeal Photopheresis (ECP)

Calculates Uvadex® (8-MOP) dose, treatment volume, and eligibility check for ECP procedures. Supports both inline (Therakos® CELLEX®) and offline (Spectra Optia cMNC) methods.

Uvadex Dosing Formula (FDA-Approved)

Uvadex Dose (mL) = Treatment Volume (mL) × 0.017 8-MOP Concentration = Uvadex Dose × 20 mcg/mL × 1000 / Treatment Volume Target: 200 ng/mL in the buffy coat layer

Uvadex = 20 mcg/mL methoxsalen. The 0.017 factor is the FDA-approved dosing constant for the CELLEX system. Minimum eligibility: Hgb >10 g/dL, PLT >20×10⁹/L, weight ≥20 kg (inline).

📖 Therakos CELLEX PI · FDA Label for Uvadex · ASFA 9th Edition Cat I (CTCL), Cat II (GvHD)

ECP Method

Inline — Therakos CELLEX Offline — Spectra Optia cMNC

Patient Weight (kg)

Hemoglobin (g/dL) Eligibility threshold: >10 g/dL

Platelet Count (×10⁹/L) Eligibility threshold: >20×10⁹/L

Lymphocyte Count (×10⁹/L) — optional Eligibility threshold: ≥1.0×10⁹/L

Treatment Volume (mL) — Inline CELLEX default: 240 mL

Buffy Coat Volume (mL) — Offline

Saline Dilution Volume (mL) — Offline

MNC Count (×10⁹/L) — optional For MNC dose/kg estimate

☀️ ECP Prescription Results

Uvadex Dose
—
mL (add to treatment bag)

Treatment Volume
—
mL

8-MOP Concentration

—

ng/mL (target: 200 ng/mL)

Eligibility Check

—

standard criteria

Recommended Device Setting

—

device-specific

Estimated MNC Dose

—

×10⁶/kg (estimated)

Indication	ASFA Category	Grade	Notes
CTCL (Erythrodermic MF/SS)	I	1B	First-line for erythrodermic stage
Acute GvHD (steroid-refractory)	II	2C	Second-line; used with steroids
Chronic GvHD	I	1B	Well-established; skin, liver, lung
Cardiac Transplant Rejection	II	1B	Prophylaxis and rejection treatment
Lung Transplant — BOS	II	1C	Bronchiolitis obliterans syndrome

Apheresis Clinical Calculators

Patient Body Parameters Live

Nadler's Formula for Total Blood Volume (TBV)

📊 Patient Parameters

Therapeutic Plasma Exchange (TPE) Live

TPE Volume & Solute Removal

📊 TPE Prescription

Solute Removal Kinetics

One-Compartment Removal Model

📊 Predicted Removal by Session

RBC Exchange — Procedure Setup Live

RBC Exchange Core Formulas

Patient Data

Fluid Data

Run Targets

📊 RBC Exchange — Procedure Setup Results

RBC Exchange (RBCX) — Sickle Cell Disease Live

Core Formulas — Automated RBC Exchange

🔴 RBC Exchange Results

Leukocytapheresis — WBC Reduction

WBC Reduction Estimate

📊 Leukocytapheresis Estimates

HPC Stem Cell Collection (Leukapheresis)

CD34+ Yield Prediction

📊 HPC Collection Prediction

Platelet Collection Efficiency (CE)

Collection Efficiency Formulas

📊 Plateletpheresis Results

Citrate Toxicity Risk Assessment Live

Citrate Infusion Rate

📊 Citrate Toxicity Assessment

LDL Apheresis Efficacy Live

LDL Reduction & Kroon Formula

📊 LDL Apheresis Efficacy

Replacement Fluid Calculator (TPE)

Replacement Fluid Formulas

💧 Replacement Fluid Prescription

Immunoadsorption (IA) — IgG Removal

Immunoadsorption IgG Removal

🔬 Immunoadsorption Results

Double Filtration Plasmapheresis (DFPP)

DFPP Sieving & Removal Formulas

🔁 DFPP Sieving Results

Extracorporeal Volume (ECV) Safety Check Live

ECV Safety Threshold

🛡️ ECV Safety Assessment

Extracorporeal Photopheresis (ECP)

Uvadex Dosing Formula (FDA-Approved)

☀️ ECP Prescription Results